News
HSCS
0.0974
-2.50%
-0.0025
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Processa Pharma (NASDAQ:PCSA) shares moved upwards by 31.2% to $2.12 during Thursday's pre-market session. Cyclacel Pharmaceuticals stock rose 23.04% and Compass Therapeutics shares rose 21.62%. Can Fite Biofarma (AMEX:CANF) stock also moved upwards.
Benzinga · 1d ago
HEARTSCIENCES ANNOUNCES GRANT OF FUNDAMENTAL PATENT BY THE EUROPEAN PATENT OFFICE COVERING ASSESSMENT OF DIASTOLIC FUNCTION OF THE HEART USING AI-ECG
Reuters · 2d ago
Weekly Report: what happened at HSCS last week (0415-0419)?
Weekly Report · 4d ago
Weekly Report: what happened at HSCS last week (0408-0412)?
Weekly Report · 04/15 12:12
Weekly Report: what happened at HSCS last week (0401-0405)?
Weekly Report · 04/08 12:19
HeartSciences to Present at the LD Micro Invitational XIV Conference
Chief Executive Officer Andrew Simpson is scheduled to present at the LD Micro Invitational XIV Conference on April 9, 2024. Heart Test Laboratories, Inc. Is a medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The conference will be held in New York.
Barchart · 04/02 15:15
Weekly Report: what happened at HSCS last week (0325-0329)?
Weekly Report · 04/01 12:15
Weekly Report: what happened at HSCS last week (0318-0322)?
Weekly Report · 03/25 12:18
Weekly Report: what happened at HSCS last week (0311-0315)?
Weekly Report · 03/18 12:17
HSCS Stock Earnings: Heart Test Laboratories Beats EPS for Q3 2024
Heart Test Laboratories reported earnings per share of -3 cents. The company reported revenue of $14,700. This was above the analyst estimate for EPS of -6 cents. Heart Test Laboratories was down 2% after the market closed on Wednesday.   
Investorplace · 03/15 01:54
Recap: Heart Test Laboratories Q3 Earnings
Heart Test Laboratories reported its Q3 earnings on March 14. Heart Test Laboratories beat estimates by 50.0%. The company's revenue was up $12 thousand from the same period last year. The company is expected to report its earnings on Thursday, March 14 at 4:00pm.
Benzinga · 03/14 21:45
Heart Test Laboratories reports Q3 results
Seeking Alpha · 03/14 21:16
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results
Heart Test Laboratories, Inc. Reports financial results for the third quarter fiscal 2024 ended January 31, 2024. The company is an artificial intelligence-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Heart Test Laboratories reports a business update.
Barchart · 03/14 15:15
HeartSciences' Announces Peer-Reviewed Publication Evaluating Use Of MyoVista Technology To Detect Asymptomatic Left Ventricular Dysfunction In Patients With Type 2 Diabetes
Heart Test Laboratories, Inc. Announces publication in Cardiovascular Diabetology of an independent, peer-reviewed study utilizing its MyoVista proprietary technology. The study evaluated the accuracy of an AI-ECG model in screening for heart failure in type 2 diabetes patients. HeartSciences is a company focused on transforming ECGs/EKGs to save lives.
Benzinga · 03/12 13:07
Weekly Report: what happened at HSCS last week (0304-0308)?
Weekly Report · 03/11 12:11
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
United Natural Foods shares dipped 15.2% to $12.61 on Wednesday. The company posted adjusted earnings of 7 cents per share in second-quarter. Rail Vision Ltd. Shares jumped 115.2%. Airship AI Holdings, Inc. Shares climbed 37.8% after gaining 200% on Tuesday.
Benzinga · 03/06 18:54
12 Health Care Stocks Moving In Wednesday's Intraday Session
Aptorum Gr (NASDAQ:APM) stock moved upwards by 780.6% to $12.77 during Wednesday's regular session. NKGen Biotech stock rose 302.55% and Vincerx Pharma shares rose 37.61% during the session. The company's market cap stands at $75.9 million.
Benzinga · 03/06 17:31
Is Zillow (Z) Stock on the Brink of Death? This Short Seller Thinks So.
Zillow stock is down 1.7% today after a short report from Spruce Point Capital. The firm says Zillow is in trouble due to weakening demand in the home-buying sector. Z stock could fall to between $23 and $35 per share over the long term. Today's stock market news includes news of JD.com (NASDAQ:JD), Palantir and Heart Test Laboratories.
Investorplace · 03/06 15:39
Dow Jumps 200 Points; Abercrombie & Fitch Posts Upbeat Profit
Abercrombie & Fitch posted better-than-expected results for its fourth quarter on Wednesday. The Dow Jones gained around 200 points on Wednesday, while the NASDAQ and S&P 500 also traded higher. Information technology shares jumped by 1% on Wednesday; financial shares rose by just 0.2%. Asian markets closed mixed on Wednesday while European shares were higher.
Benzinga · 03/06 14:49
More
Webull provides a variety of real-time HSCS stock news. You can receive the latest news about Heart Test Laboratories through multiple platforms. This information may help you make smarter investment decisions.
About HSCS
Heart Test Laboratories, Inc., doing business as HeartSciences, is an artificial intelligence electrocardiogram (AI ECG) company. The Company is focused on using AI to transform ECG to save lives through earlier detection of heart disease. The Company’s initial focus is on applying technology to extend the clinical indications for use of an electrocardiograph (ECG) device. Its first device, the MyoVista is an ECG that can be used in a range of clinical settings and provides diagnostic information to a qualified healthcare professional on cardiac dysfunction which has traditionally only been provided using cardiac imaging. In addition, MyoVista provides conventional ECG information. The Company focuses on marketing its device both domestically and internationally to various hospitals, clinics, and medical centers and manufacturing the devices using outsourced production facilities.